Before Dostinex became available in the U.S., the only other dopamine agonist approved for the treatment of increased levels of prolactin was bromocriptine. Dostinex has a number of advantages over bromocriptine: lower incidence of side effects, twice weekly dosing versus 2-3 times daily for bromocriptine, and generally more effective, especially in those in which bromocriptine was ineffective.
Hope this helps,
Emo
Hope this helps,
Emo